Documents / Report
This Defense Intelligence Agency reference document, dated 31 March 2010 (DIA-08-1003-020), was one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications (AAWSA) program. It surveys biosensors and BioMEMS, covering brain-implanted neuroelectrodes, drug-delivery pumps, implantable glucose sensors, brain-machine interfaces, retinal prostheses, microfluidic lab chips, NASA cell culture systems, and microcantilever sensors. It concludes that the field is expanding rapidly toward nanomechanical systems.
“Roe”1 page
UNCLASSIFIED/ ,'1"91'1 91"1"!!!11tt tl!!II!! 9HL"i' move through the channels where processes of separation, filtering, mixing, heating, reaction, and waste disposal can occur in a programmed sequence. Color changes after a sequence of chemical steps might be used to indicate the presence and concentration of an analyte. Optical absorbance or transparency can be read by a simple light emitting diode (LED) and photodetector system that measures light passing through the glass sample cell. LAB CHIPS A class of microfluidic devices known as lab-chips or Lab-on-a-Chip (LOC) have made their appearance in the market place. These devices are miniature chemical analysis systems that replace many of the manual and laborious steps associated with analytical chemistry. They are generally produced by MEMS techniques and often, but not always, incorporate electrical systems on the devices. Automated MEMS-based lab-on-a-chip platforms have become an established system for basic life science research and drug discovery. They are used to assess the characteristics of isolated DNA or proteins. One of the most useful products of bioMEMS instrumentation is the ability to manipulate small quantities of DNA using microfluidic pathways to perform chemistry with only the content from a single cell. BioMEMs enable new techniques in genomics (the study of sets of genes, gene products, and their interactions) and proteomics (the study of proteins, the expression of genes in health and disease). These systems are being made now by companies including Affymetix, Caliper, Nanogen, and Agilent for processing samples on a microfluidic chip for separation and detection. Figure 31 shows the variety of such systems currently on the market. Such devices can replace a number of gel electrophoresis operations and substantially improve work flow sample handling and analysis, lower per sample analysis by l0X and minimize sample and reagent use. The physics of these microfluidic systems enable some unique features, including smooth laminar flow through the microchannels, high surface area to volume ratios, small thermal mass, and strong effects by electric fields. Microfluidic devices also lend themselves to enhancements for single cell detection, fluorescence detection, sorting schemes, and unique fluid separation methods. The advantages of lab-on-chip devices include: • Improved fluid transport by electrokinetic effects and miniaturized pumps. • Efficient molecular and particle separation and immobilization. • Smaller sample requirements and carrier volumes. • Reduced reagent consumption and expense. • Integration of channels, mixers, separators, reaction chambers, electrodes, and detectors into single devices. 33 UNCLASSIFIED//F8R 8Ffl@Itllt t,31!! enc I
Not linked to a story yet.
Report, from the dia collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.